These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19585385)

  • 61. Improved quality of life and enhanced satisfaction after TURP: prospective 12-year follow-up study.
    Mishriki SF; Grimsley SJ; Nabi G; Martindale A; Cohen NP
    Urology; 2008 Aug; 72(2):322-6; discussion 326-8. PubMed ID: 18533236
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prostate volume and age are predictors of energy delivery using the CoreTherm Concept in patients with LUTS/BPO: a study on thermal dose.
    Stenmark F; Brudin L; Kjölhede H; Peeker R; Stranne J
    Scand J Urol; 2020 Jun; 54(3):248-252. PubMed ID: 32401123
    [No Abstract]   [Full Text] [Related]  

  • 63. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature.
    Oeconomou A; Madersbacher H; Kiss G; Berger TJ; Melekos M; Rehder P
    Eur Urol; 2008 Oct; 54(4):765-75. PubMed ID: 18571306
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of the Schelin Catheter for transurethral intraprostatic anesthesia prior to Rezūm treatment.
    Hamouda A; Ibrahim A; Corsi N; Siena G; Elterman DS; Chughtai B; Bhojani N; Sessa F; Rivetti A; Secco S; Zorn KC
    Can J Urol; 2024 Feb; 31(1):11802-11808. PubMed ID: 38401260
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Injectables in the prostate.
    Saemi AM; Plante MK
    Curr Opin Urol; 2008 Jan; 18(1):28-33. PubMed ID: 18090486
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
    Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A
    BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
    Jeldres C; Isbarn H; Capitanio U; Zini L; Bhojani N; Shariat SF; Cloutier V; Lattouf JB; Duclos A; Jolivet-Tremblay M; Valiquette L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Aug; 182(2):626-32. PubMed ID: 19535100
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Value of transurethral resection of the prostate (TURP) for treatment of symptomatic benign prostatic obstruction (BPO): an analysis of efficiency and complications in 1015 cases].
    Zepnick H; Steinbach F; Schuster F
    Aktuelle Urol; 2008 Sep; 39(5):369-72. PubMed ID: 18798126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Changes in prostatic circulation in response to laser therapy and magnetic therapy in patients with benign prostatic hyperplasia].
    Urologiia; 2005; (6):16-8. PubMed ID: 16419474
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Histopathologic changes due to combination of androgen deprivation and transurethral microwave thermotherapy in patients with localized prostate cancer].
    Suzuki R; Jujo Y; Koshiba K; Hoshiai O; Endo T; Aihara M; Nakajo H; Ohori M
    Hinyokika Kiyo; 2009 Feb; 55(2):79-85. PubMed ID: 19301612
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity.
    Mavuduru RM; Mandal AK; Singh SK; Acharya N; Agarwal M; Garg S; Kumar S
    Urol Int; 2009; 82(2):130-5. PubMed ID: 19321996
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comparison of holmium and thulium laser in transurethral enucleation of the prostate].
    Shao Q; Zhang FB; Shang DH; Tian Y
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):346-9. PubMed ID: 19472910
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Thermotherapy with feedback (PLFT) in the treatment of prostatic adenoma].
    Spivak LG; Demidko IuL; Vinarov AZ
    Urologiia; 2006; (4):73-6. PubMed ID: 17058690
    [No Abstract]   [Full Text] [Related]  

  • 75. [TUBVP and HOLEP: desirable surgical options for large benign prostatic hyperplasia ( >80 ml)].
    Zhu QY; Gu XJ; Yuan L; Huang WZ; Zhang L; Lu ZJ; Zhang P; Su J; Xu Y; Zhang Y
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):907-10. PubMed ID: 19157101
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The effect of Yunnan Baiyao on reduction of intra-operative bleeding of the patients undergoing transurethral resection of prostate].
    Li NC; Pan BN; Wang HJ; Li HZ; Wei Q; Wang XH; Cai SL; Gan WM; Na YQ
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1017-20. PubMed ID: 17672962
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bipolar transurethral resection of the prostate: the 'golden standard' reclaims its leading position.
    Mamoulakis C; Trompetter M; de la Rosette J
    Curr Opin Urol; 2009 Jan; 19(1):26-32. PubMed ID: 19057207
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Transurethral prostatectomy with the bipolar plasmakinetic technique for benign prostate hyperplasia: a report of 712 cases].
    Che XY; Song XS; Wu DJ; Wang FP; Wang QF; Wang JB
    Zhonghua Nan Ke Xue; 2009 May; 15(5):449-51. PubMed ID: 19514560
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate.
    Siena G; Sessa F; Cindolo L
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):147-149. PubMed ID: 36639547
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.